Editorial: Juvenile Spondyloarthritis: From Basic Science to Clinical Translation
- PMID: 35345764
- PMCID: PMC8957199
- DOI: 10.3389/fmed.2022.861512
Editorial: Juvenile Spondyloarthritis: From Basic Science to Clinical Translation
Keywords: biomarkers; classification; juvenile spondyloarthritis (JSpA); outcome; pathophysiology; therapy; translational science.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Juvenile Spondyloarthritis: From Basic Science to Clinical Translation
References
-
- Ruperto N, Foeldvari I, Alexeeva E, Aktay N, https://www.researchgate.net/profile/Inmaculada-Penades Penad'es IC, Kasapcopur O LB0004. Efficacy safety of secukinumab in enthesitis-related arthritis juvenile psoriatic arthritis: primary results from a randomized, double-blind, placebo-controlled, treatment withdrawal, phase 3 study (JUNIPERA). Ann Rheum Dis. (2021) 80:201–2. 10.1136/annrheumdis-2021-eular.5038 - DOI - PubMed
-
- Goirand M, Breton S, Chevallier F, Duong NP, Uettwiller F, Melki I, et al. . Clinical features of children with enthesitis-related juvenile idiopathic arthritis/juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre. Pediatr Rheumatol Online J. (2018) 16:21. 10.1186/s12969-018-0238-9 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
